Vimarsana
Biggest News Aggregation in the World

Triad Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Triad Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Triad Life Sciences Today - Breaking & Trending Today

Convatec feels pain of new rules surrounding America's Medicare - Vimarsana News

Convatec feels pain of new rules surrounding America's Medicare

New restrictions on tissue-based products will hit the bottom line of medical products group, warns broker

Anti-biofilm Wound Dressing Market Growth 2023 to 2033 | By Urgo Medical, Coloplast, ConvaTec, Smith - Vimarsana News

Anti-biofilm Wound Dressing Market Growth 2023 to 2033 | By Urgo Medical, Coloplast, ConvaTec, Smith

The global Anti-biofilm Wound Dressing market demand is expected to increase at a 9.5% CAGR between 2023 and 2033, from US$ 782.60 million in 2023 to more than US$ 1939.45 million by 2033. The prevalence of chronic and acute wounds is expected to rise in the coming years, increasing the demand for Anti-biofilm Wound...

Advanced Wound Dressing Products Industry Ramps Up Investments in Foam Dressings - Vimarsana News

Advanced Wound Dressing Products Industry Ramps Up Investments in Foam Dressings

SAN FRANCISCO, May 31, 2023 /PRNewswire/ -- The global advanced wound dressing products industry size stood at USD 7.4 billion in 2022 and is expected to witness a 4.46% CAGR from 2023 to 2030

Convatec increases revenue guidance - Vimarsana News

Convatec increases revenue guidance

Convatec increases revenue guidance

Anti-biofilm Wound Dressing Market is predicted to reach from US$ 782.60 million in 2023 | Exclusive - Vimarsana News

Anti-biofilm Wound Dressing Market is predicted to reach from US$ 782.60 million in 2023 | Exclusive

The net worth of the market share of the anti-biofilm wound dressing is predicted to reach from US$ 782.60 million in 2023 to over US$ 1939.45 million by 2033, recording a CAGR of 9.5% between 2023 and 2033. Incidence rates for chronic and acute wounds are expected to increase which is, driving demand for anti-biofi...